The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
暂无分享,去创建一个
Jiaying Tan | Venkatesha Basrur | James A. Connelly | Yongsheng Huang | Yongsheng Huang | J. Hess | K. Elenitoba-Johnson | J. Bronstein | V. Basrur | K. Sitwala | Jay L. Hess | Andrew G Muntean | A. Muntean | Andrew G. Muntean | Kajal Sitwala | Joel Bronstein | Kojo S. J. Elenitoba-Johnson | J. Connelly | Jiaying Tan | Kajal V. Sitwala
[1] R. Thakker,et al. Parafibromin – functional insights , 2009, Journal of internal medicine.
[2] Toshiki Mori,et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. , 2002, Molecular cell.
[3] J. Fisher,et al. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. , 2007, Cell stem cell.
[4] Paul Tempst,et al. Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. , 2005, Molecular cell.
[5] Laurence Florens,et al. Histone Crosstalk between H2B Monoubiquitination and H3 Methylation Mediated by COMPASS , 2007, Cell.
[6] D. Reinberg,et al. Histone H2B Monoubiquitination Functions Cooperatively with FACT to Regulate Elongation by RNA Polymerase II , 2006, Cell.
[7] S. Korsmeyer,et al. Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.
[8] Thomas A Milne,et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. , 2002, Molecular cell.
[9] Peng Fei Wang,et al. Molecular Regulation of H3K4 Trimethylation by Wdr82, a Component of Human Set1/COMPASS , 2008, Molecular and Cellular Biology.
[10] D. Kioussis,et al. Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. , 2007, Cell stem cell.
[11] Babak Shahbaba,et al. A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. , 2009, Blood.
[12] Richard A Young,et al. Exchange of RNA polymerase II initiation and elongation factors during gene expression in vivo. , 2002, Molecular cell.
[13] N. Thompson,et al. A novel collection of accessory factors associated with yeast RNA polymerase II. , 1996, Protein expression and purification.
[14] N. Zeleznik-Le,et al. MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression , 2008, Proceedings of the National Academy of Sciences.
[15] Scott A. Armstrong,et al. MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.
[16] O. Rozenblatt-Rosen,et al. The Parafibromin Tumor Suppressor Protein Is Part of a Human Paf1 Complex , 2005, Molecular and Cellular Biology.
[17] Thomas A Milne,et al. Interaction of MLL amino terminal sequences with menin is required for transformation. , 2005, Cancer research.
[18] Akihiko Yokoyama,et al. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. , 2008, Cancer cell.
[19] M. Cleary,et al. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. , 2003, Genes & development.
[20] Mark Johnston,et al. Methylation of Histone H3 by COMPASS Requires Ubiquitination of Histone H2B by Rad6* , 2002, The Journal of Biological Chemistry.
[21] Xiaobo Xia,et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.
[22] John H Kersey,et al. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. , 2004, Blood.
[23] K. Yoshimoto,et al. Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen , 2007, Oncogene.
[24] Kevin Struhl,et al. The Rtf1 Component of the Paf1 Transcriptional Elongation Complex Is Required for Ubiquitination of Histone H2B* , 2003, Journal of Biological Chemistry.
[25] A. Shilatifard,et al. RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human Cells , 2009, Cell.
[26] Y Wang,et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.
[27] M. García-Cuéllar,et al. Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2 , 2009, Oncogene.
[28] A. Chinnaiyan,et al. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. , 2007, Blood.
[29] J. Hess,et al. MLL associates specifically with a subset of transcriptionally active target genes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] O. Rozenblatt-Rosen,et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] Howard Y. Chang,et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. , 2009, Cell stem cell.
[32] M. Johnston,et al. The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. , 2003, Molecular cell.
[33] Steven Hahn,et al. Phosphorylation of the Transcription Elongation Factor Spt5 by Yeast Bur1 Kinase Stimulates Recruitment of the PAF Complex , 2009, Molecular and Cellular Biology.
[34] J. Rowley,et al. Chromatin structural elements and chromosomal translocations in leukemia. , 2006, DNA repair.
[35] M. Cleary,et al. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.
[36] T. Kitamura,et al. Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.
[37] W. Simonds,et al. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression , 2005, Oncogene.
[38] Herbert Schulz,et al. A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. , 2009, Cell stem cell.
[39] Paul Tempst,et al. The human PAF complex coordinates transcription with events downstream of RNA synthesis. , 2005, Genes & development.
[40] M. Bycroft,et al. Solution structure of the nonmethyl‐CpG‐binding CXXC domain of the leukaemia‐associated MLL histone methyltransferase , 2006, The EMBO journal.
[41] Zu-Wen Sun,et al. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast , 2002, Nature.
[42] C. Larsson,et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Human molecular genetics.
[43] M. Cleary,et al. Binding to Nonmethylated CpG DNA Is Essential for Target Recognition, Transactivation, and Myeloid Transformation by an MLL Oncoprotein , 2004, Molecular and Cellular Biology.
[44] E. Lander,et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.
[45] J. Sikela,et al. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis , 2006, Oncogene.
[46] M. Cleary,et al. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. , 2010, Cancer cell.
[47] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[48] S. Chew,et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. , 1995, American journal of human genetics.
[49] P. Aplan,et al. Chromosomal translocations involving the MLL gene: molecular mechanisms. , 2006, DNA repair.
[50] S. Batra,et al. Isolation and characterization of a complementary DNA (PD-1) differentially expressed by human pancreatic ductal cell tumors. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[51] C. Allis,et al. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Hess. MLL: a histone methyltransferase disrupted in leukemia. , 2004, Trends in molecular medicine.